Sign in to view content

Abicipar for nAMD Provides Faster Retinal Fluid Resolution, and Achieved Similar Dryness Through Week 104 With Fewer Injections

Nancy M. Holekamp, MD, FASRS

Video
Published 2020

Related

High-dose Aflibercept Therapy in nAMD and DME Eyes With Suboptimal Response to Standard Dose of Anti-VEGF Therapy: A Retrospective Analysis
Jared S. Nielsen, MD, MBA
Annual Meeting Talks
2020
Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration
Jeffrey S. Heier, MD
Annual Meeting Talks
2021
Medical Case Conference: Narciso Atienza, MD, MBA, FASRS, FPCS, FPAO
Narciso F. Atienza, MD, MBA, FASRS, FPCS, FPAO.
Annual Meeting Talks
2024

Category: AMD-Neovascular

See more